Mayinglong Pharmaceutical Group Co Ltd, Wuhan, China – FDA Inspections

Inspection records and compliance data for Mayinglong Pharmaceutical Group Co Ltd in Wuhan. 3 FDA inspections on record, 2 Form 483s, last inspected March 14, 2025.

Company Profile

This profile covers Mayinglong Pharmaceutical Group Co Ltd based in Wuhan, China.

FDA Inspection History

FDA inspections: 3
OAI: 0
VAI: 3
NAI: 0
Form 483s: 2
Warning letters: 0

First inspected December 11, 2015. Last inspected March 14, 2025.

Most cited issue areas

Adequate number of batches on stability1 inspection

FDA inspections (3)

Date	Result	FDA center(s)	Insp. #
March 14, 2025	VAI	Human Drugs · Drug Quality Assurance	1264613
April 13, 2018	VAI	Human Drugs · Drug Quality Assurance	1051249
December 11, 2015	VAI	Human Drugs · Drug Quality Assurance	955742

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

NasPress Pharmaceutical Co., Ltd.

Guangdong Comfort Medical Products Co., Ltd.

Nantong Health & Beyond Hygienic Products Inc.

Jilin Shengtong Chemical Co., Ltd.

Zhejiang Ayan Biotech Co.,Ltd.

Jiangxi Sanyuan Pharmaceutical Co., Ltd.

Jinhua Jingdi Medical Supplies Co., Ltd.

Chenggu Zhenhua Biological Science & Technology Co., Ltd.

Shenzhen Senton Science & Technology Co.,Ltd.

ZHEJIANG JINGHUI COSMETICS SHARE CO.,LTD